Richard S. Irwin, MD, Master FCCP; on behalf of the CHEST Expert Cough Panel* BACKGROUND: The decision to treat a suspected case of pertussis with antibiotics is usually based on a clinical diagnosis rather than waiting for laboratory confirmation. The current guideline focuses on making the clinical diagnosis of pertussis-associated cough in adults and children.
Summary of Recommendations:
1. For adult patients complaining of acute cough (< 3 weeks in duration) or subacute cough (3-8 weeks), we suggest that clinicians should specifically assess for the 4 key characteristics of paroxysmal cough, posttussive vomiting, inspiratory whooping, and absence of fever in ruling in or out a clinical diagnosis of pertussis. (Grade 2C)
Remark: Paroxysmal cough is defined as recurrent prolonged coughing episodes (ie, an expiratory phase with multiple burst of outflow) with an inability to breathe during spells. Posttussive vomiting is defined as vomiting induced by coughing. Inspiratory whooping is defined as a continuous inspiratory airway sound with a whooping quality to it. Fever is defined as any body temperature above the normal of 98. 6 F (37 C).
2. For adult patients complaining of acute or subacute cough, we suggest that clinicians consider that the cough is unlikely to be due to pertussis if the patient has a fever or the cough is not paroxysmal in nature.
(Grade 2C)
3. For adult patients complaining of acute or subacute cough, we suggest that clinicians consider that the cough is likely to be caused by pertussis if there is posttussive vomiting or is associated with an inspiratory whooping sound. (Grade 2C) 4. For children complaining of acute cough (< 4 weeks in duration), we suggest that clinicians should specifically assess for the 3 classical characteristics of paroxysmal cough, posttussive vomiting, and inspiratory whooping. (Ungraded consensus-based statement)
5. For children complaining of acute cough, we suggest that clinicians consider that the cough could be caused by pertussis if there is posttussive vomiting.
(Grade 2C) (Table 1 ).
There are several recognized laboratory methods to confirm a diagnosis of pertussis; culture (100% specific), polymerase chain reaction (88%-100% specific), serology (72%-100% specific), 4, 5 and oral fluid testing (91%-99% specific). 6 These are used variously by the different health organizations (Table 2 ).
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The treatment of pertussis has been the subject of a Cochrane systematic review. 7 There are several effective antibiotics; these eliminate B pertussis but do not alter the clinical course of the illness. However, treatment should be initiated as soon as possible after onset of illness to prevent spread of the disease. 3 The decision to treat with antibiotics is therefore frequently based on a clinical diagnosis rather than waiting for laboratory confirmation.
Because reviews of laboratory diagnosis and treatment have recently been published 7 and diagnosis is usually made clinically, the current guideline focuses on making the clinical diagnosis of pertussis-associated cough in adults and children.
Materials and Methods
The methodology of the CHEST Guideline Oversight Committee 8, 9 was used to select the Expert Cough Panel Chair and the international panel of experts to synthesize the evidence and to develop the recommendations and suggestions that are contained within this article. In addition to the quality of the evidence, the recommendation/suggestion grading also includes a strength of recommendation dimension, used for all CHEST Guidelines. 8, 9 In do not replace professional medical care and physician advice, which always should be sought for any medical condition. The complete disclaimer for this guideline can be accessed at http://www.chestnet. org/Guidelines-and-Resources/Guidelines-and-Consensus-Statements/ CHEST-Guidelines.
the context of practice recommendations, a grade 1 recommendation is a strong recommendation and applies to almost all patients, whereas a grade 2 recommendation is weak and conditional and only applies to some patients. The strength of recommendation here is based on consideration of three factors: balance of benefits to harms, patient values and preferences, and resource considerations. Harms incorporate risks and burdens to the patients that can include convenience or lack of convenience, difficulty of administration, and invasiveness. These, in turn, impact patient preferences. The resource considerations go beyond economics and should also factor in time and other indirect costs. The authors of these recommendations or suggestions have considered these parameters in determining the strength of the recommendations or suggestions and associated grades.
The findings of a systematic review and meta-analysis that was carried out to be the basis of this guideline and has recently been published 10 were used to support the evidence graded recommendations or suggestions. The first, second, and third authors of this current guideline article were among the authors of the systematic review and meta-analysis. The process of review of previous studies identified in the systematic review included assessment using the QUADAS-2 (a quality assessment tool for diagnostic accuracy studies) in the domains of patient selection, index tests, reference standard, and flow and timing. 11 When the quality of studies included in the systematic review 10 were checked using DART (Documentation and Appraisal Review Tool), 12 similar quality results were found. A highly structured consensus-based Delphi approach was employed to provide expert advice on all guidance statements. The total number of eligible voters for each guidance statement did not vary because none was recused from voting on any particular statements because of any potential conflicts of interest. A lay person representing the interests of patients participated in the process and voting. Transparency of process was documented. Further details of the methods related to conflicts of interests and transparency for all CHEST guidelines have been published in e- Table 1 and elsewhere. 8, 9 Based on the systematic review and meta-analysis 10 and the Delphi methodology described, the writing group developed guideline recommendations or suggestions. These then underwent review and consensus agreement through an online anonymous voting survey by the full cough panel. For a recommendation or suggestion to be accepted, it had to be voted upon by 75% of the eligible Cough Panelists and achieve ratings of strongly agree or agree by 80% of the voting panelists. Agreement was achieved by 87.24% to 95.75% of those voting on the current recommendations or suggestions. No panelist was excluded from voting.
Because a paroxysmal cough figures heavily in making a clinical diagnosis of a pertussis-associated cough, we have defined it as recurrent prolonged coughing episodes (ie, an expiratory phase with multiple burst of outflow) with an inability to breathe during spells.
Results
The recommendations that follow are based upon the recently published high-quality systematic review 10 that included a comprehensive search of multiple databases restricted to the English language. The systematic review followed all the standards of the National Academy of Medicine (previously referred to as the Institute of Medicine). 13 After generating the key clinical question for the systematic review, population, index test, reference test, and target chestjournal.org condition elements were derived to inform the literature review (Table 3) . 10 The After the initial screening of articles, full text review, data extraction, and quality assessment, 53 articles were identified for descriptive analysis and meta-analysis. 10 These articles included 23,796 subjects, of whom 4,149 (17.4%) had a laboratory diagnosis of pertussis. Thirtysix of the 53 articles had a prospective design, 12 were retrospective, and 5 were case-control. From these 53 studies, 41 clinical characteristics (ie, index tests) were assessed for diagnostic accuracy, including 9 cough characteristics as well as other clinical and demographic features (Table 4) . 10 After excluding from the metaanalysis studies at high risk of bias (28 studies), pooled estimates of sensitivity and specificity were generated by meta-analysis (Table 5) . Summary of the Evidence in Adults and Interpretation: After pre-specified meta-analysis exclusions, pooled estimates of sensitivity and specificity were generated for only 4 clinical features in adult patients: paroxysmal cough, posttussive vomiting, inspiratory whooping, and absence of fever. Both paroxysmal cough and absence of fever had high sensitivity and low specificity (Table 5 , e- Table 2 ). 10 This means that a patient without these features is unlikely to have a diagnosis of pertussis (few false-negatives). Inspiratory whoop and posttussive vomiting had a low sensitivity but high specificity. This means that a diagnosis of pertussis should be considered in a patient with these features (few false-positives).
For adult patients complaining of acute cough (< 3 weeks in duration) or subacute cough (3-8 weeks)
, we suggest that clinicians should specifically assess for the 4 key characteristics of paroxysmal cough, posttussive vomiting, inspiratory whooping, and absence of fever in ruling in or out a clinical diagnosis of pertussis. (Grade 2C)
Remark: Paroxysmal cough is defined as recurrent prolonged coughing episodes (ie, an expiratory phase with multiple burst of outflow) with an inability to breathe during spells. Posttussive vomiting is defined as vomiting induced by coughing. Inspiratory whooping is defined as a continuous inspiratory airway sound with a whooping quality to it. Fever is defined as any body temperature above the normal of 98.6 F (37 C).
(Grade 2C) 
Summary of the Evidence in Children and
Interpretation: After pre-specified meta-analysis exclusions, pooled estimates of sensitivity and specificity were generated for only one clinical feature in children: posttussive vomiting. Posttussive vomiting in children (ages 0-18) was only moderately sensitive and specific (Table 5 , e- Table 2 ). 
Discussion
The systematic review used to form the basis of this guideline is the largest on this topic to date. 10 The broad inclusion criteria were designed to capture the full spectrum of pertussis presentation but meant that there was significant variation in included study characteristics-including different study designs (casecontrol and retrospective/prospective cohort), those in chestjournal.org specialist populations (eg, outbreaks), and used different reference standards. While the systematic review was done according to rigorous methods, it did have limitations. For example, while assessment of quality meant that those at resultant high risk of bias were excluded from meta-analysis, heterogeneity in the remaining studies meant that only 4 characteristics could be analyzed in this way. Because the review excluded non-English studies, potentially relevant studies may have been missed. In addition, the systematic review was published in 2017, and it was based upon a literature search that was last updated in June of 2016, and studies published since this time have not been taken into account. Although data were analyzed separately for adults and children, it is important to note that the "children" category includes studies with both older children (up to 18) and young infants who may also have very different presentations of pertussis.
A second systematic review has been written on this topic within the last year. Compared with the systematic review used to compile this guideline, Ebell et al 30 used a more restrictive search strategy in Medline only and included only prospective cohort studies. Eight unique references were included compared with the systematic review used for this guideline. However, these references were excluded from our systematic review for the following reasons: 4 had no comparison group, 2 compared pertussis with parapertussis, 1 had no clinical information, and 1 was not in English. In Ebell et al, 30 meta-analysis was done for all index tests with no comment on heterogeneity, and index tests were only analyzed separately in adults and children for paroxysmal cough, whooping cough, and posttussive vomiting. For these reasons, it was felt that the findings of Ebell et al should not be taken into account in compiling this guideline.
The existing clinical criteria in use by multiple health agencies (Table 1) 1-3 contain the index tests shown in the meta-analysis to be useful in the diagnosis of pertussis and recommended/suggested by this guideline. The presence of whooping or posttussive vomiting is common to the CDC, Public Health England, and World Health Organization clinical criteria, whereas paroxysms of coughing is included by just the CDC and World Health Organization. Apnea and cyanosis are mentioned in relation to infants aged < 1 year in the CDC criteria and were shown in forest plots in the systematic review (e-Appendix 2) 10 to be moderately sensitive and specific in children.
Areas for Future Research
To advance the field, a number of research endeavors to address the gaps in knowledge should be undertaken. These include conducting further large prospective studies in primary care of patients presenting with acute or subacute cough, particularly in infants and children.
To improve on the problems in study design identified by the systematic review, the following would be needed: detailed epidemiological/baseline characteristics of included patients, time since symptom onset recorded rather than acting as inclusion criteria, clear definitions of clinical characteristics recorded, characteristics recorded at presentation and ideally subsequently in a symptom diary. It would also be helpful to assess clinical judgment as part of this. Individual patient analysis would help assess the diagnostic utility of different symptoms in combination. 
Conclusions
Cough due to pertussis in adults and children has been the sole focus in this update, compared with one of many causes of postinfectious cough in the 2006 CHEST Cough Guidelines. 31 This guideline focuses on how to make the clinical diagnosis of pertussis because this is how the decision to treat with antibiotics is usually made. This guideline is based upon a high-quality systematic review, and it identifies gaps in our knowledge and areas for future research; we therefore believe it advances the field.
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